ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

ASCO and CAP Issue Guideline To Improve HER2 Testing

October 25, 2013

In Brief: Kirsten To Join NCI As Head of FCRF, AIDS Vaccine Development Thaddeus Domanski Dies

February 5, 1988

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001